Cover ImageSALE
Market Research Report

Global Sphygmomanometer Market 2017-2021

Published by TechNavio (Infiniti Research Ltd.) Product code 541273
Published Content info 83 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Sphygmomanometer Market 2017-2021
Published: August 9, 2017 Content info: 83 Pages
Description

About Sphygmomanometer

A sphygmomanometer is a device used to monitor the BP (both systolic and diastolic) of an individual. Various parameters such as pulse rate and heartbeat rate can be monitored in addition to BP from a single device. The most commonly monitored parameters are body temperature, blood glucose, and BP. People use these monitoring devices in their day-to-day life and does not require a medical supervision for that. BP monitoring is very important, as higher the BP, higher is the risk of associated health problems.

Technavio's analysts forecast the global sphygmomanometer market to grow at a CAGR of 7.81% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global sphygmomanometer market for 2017-2021. To calculate the market size, the report considers revenue generated from the sales of sphygmomanometers.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Sphygmomanometer Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • OMRON
  • A&D Company
  • Rudolf Riester
  • Welch Allyn

Other Prominent Vendors

  • AC Cossor & Son
  • ARCHOS
  • Amico
  • Briggs Healthcare
  • CONTEC MEDICAL SYSTEMS
  • ERKA
  • EXANOVO
  • Fazzini
  • Ferno
  • HEINE
  • HOLTEX +
  • Jiangsu folee medical equipment
  • Microlife Corporation
  • Qufu Longercare Meditech
  • Rossmax International
  • SAN UP
  • SPENGLER
  • SunTech Medical
  • SUZUKEN
  • Timesco Healthcare
  • TROGE MEDICAL
  • Yu Yue medical

Market driver

  • Increasing awareness about hypertension and its associated risks
  • For a full, detailed list, view our report

Market challenge

  • Inaccurate readings on digital sphygmomanometers
  • For a full, detailed list, view our report

Market trend

  • Development of cloud-based healthcare system
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents
Product Code: IRTNTR14254

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product

  • Market overview
  • Electronic sphygmomanometer
  • Aneroid sphygmomanometer
  • Mercury sphygmomanometer

PART 07: Market segmentation by end-user

  • Market overview
  • Hospitals
  • Homecare
  • ASCs

PART 08: Geographical segmentation

  • Market overview
  • Americas
  • EMEA
  • APAC

PART 09: Decision framework

PART 10: Drivers and challenges

  • Market drivers
  • Market challenges

PART 11: Market trends

  • Development of cloud-based healthcare system
  • Evolution of advanced sphygmomanometers
  • Technological advances

PART 12: Vendor landscape

  • Competitive landscape
  • Other prominent vendors

PART 13: Key vendor analysis

  • A&D Company
  • OMRON
  • Rudolf Riester (a subsidiary of Halma)
  • Welch Allyn (part of the Hill-Rom family of companies)

PART 14: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Associated diseases with hypertension as major risk factor
  • Exhibit 02: Market scenario of sphygmomanometers 2016 and 2021
  • Exhibit 03: Global sphygmomanometer market 2016-2021 ($ millions)
  • Exhibit 04: Global sphygmomanometer market by product 2016-2021 (%)
  • Exhibit 05: Global sphygmomanometer market by geography 2016 ($ millions)
  • Exhibit 06: Five forces analysis
  • Exhibit 07: Global sphygmomanometer market segmentation by product 2016 and 2021 (%)
  • Exhibit 08: Global electronic sphygmomanometer market 2016-2021 ($ millions)
  • Exhibit 09: Global aneroid sphygmomanometer market 2016-2021 ($ millions)
  • Exhibit 10: Global mercury sphygmomanometer market 2016-2021 ($ millions)
  • Exhibit 11: Global sphygmomanometer market analysis by end-user
  • Exhibit 12: Global sphygmomanometer market overview by end-user segmentation
  • Exhibit 13: Global sphygmomanometer market by geography 2016 (%)
  • Exhibit 14: Global sphygmomanometer market by geography 2021 (%)
  • Exhibit 15: Global sphygmomanometer market overview by geography
  • Exhibit 16: Sphygmomanometer market in Americas 2016-2021 ($ millions)
  • Exhibit 17: Sphygmomanometer market overview in US
  • Exhibit 18: Sphygmomanometer market in EMEA 2016-2021 ($ millions)
  • Exhibit 19: Sphygmomanometer market overview in Germany
  • Exhibit 20: Sphygmomanometer market in APAC ($ millions)
  • Exhibit 21: Sphygmomanometer market overview in Japan
  • Exhibit 22: Hypertension demographics and economic burden of associated diseases
  • Exhibit 23: A&D Company: Key highlights
  • Exhibit 24: A&D Company: Strength assessment
  • Exhibit 25: A&D Company: Strategy assessment
  • Exhibit 26: A&D Company: Opportunity assessment
  • Exhibit 27: OMRON: Key highlights
  • Exhibit 28: OMRON: Strength assessment
  • Exhibit 29: OMRON: Strategy assessment
  • Exhibit 30: OMRON: Opportunity assessment
  • Exhibit 31: Rudolf Riester: Key highlights
  • Exhibit 32: Rudolf Riester: Strength assessment
  • Exhibit 33: Rudolf Riester: Strategy assessment
  • Exhibit 34: Rudolf Riester: Opportunity assessment
  • Exhibit 35: Welch Allyn: Key highlights
  • Exhibit 36: Welch Allyn: Strength assessment
  • Exhibit 37: Welch Allyn: Strategy assessment
  • Exhibit 38: Welch Allyn: Opportunity assessment
Back to Top